Business Context and Reporting Period
This Form 6-K filing by Xiaobai Maimai Inc. (referred to in metadata as Akso Health Group) covers the month of September 2021, specifically dated September 2, 2021. The report announces a significant change in executive management.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance and does not contain financial statements.
Material Changes
The primary material change reported is the appointment of Ms. Yilin (Linda) Wang as Co-Chief Executive Officer (Co-CEO), effective September 1, 2021.
Management Commentary and Risks
- Executive Background: Ms. Wang brings extensive experience in corporate management, having served as Director and CEO of SOS Information Technology Co., Ltd. since March 2016, and as founder and CEO of Shijiazhuang Weigou Information Technology Co., Ltd. since November 2010.
- Expertise: She is identified as an information technology expert with professional experience in medical health, health management, and medical technology-related businesses.
- Related Party Transactions: The Company confirmed no family relationships between Ms. Wang and existing executive officers or directors. Furthermore, there have been no transactions in the past two years involving the Company or its subsidiaries in which Ms. Wang had a direct or indirect material interest.
- Employment Agreement: An employment agreement was entered into on September 1, 2021, and is filed as Exhibit 99.1.
Investor Verification Checklist
- Verify the terms of the employment agreement filed as Exhibit 99.1.
- Confirm the strategic rationale for appointing a Co-CEO with a background in SOS Limited and medical technology.
- Monitor future filings for any financial impact or strategic shifts resulting from this leadership change.